These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 542110)

  • 1. [Bromocriptin in Parkinson's syndrome].
    Völler GW; Ulm G
    Med Welt; 1979 Dec; 30(51-52):1930-3. PubMed ID: 542110
    [No Abstract]   [Full Text] [Related]  

  • 2. [Crises in the course of Parkinson's disease].
    Danielczyk W
    Wien Med Wochenschr; 1980 Feb; 130(4):149-51. PubMed ID: 7376682
    [No Abstract]   [Full Text] [Related]  

  • 3. [Parkinsonian syndrome caused by carbon monoxide poisoning. Preliminary results of the treatment with bromocriptine].
    De Pooter MC; Leys D; Godefroy O; De Reuck J; Petit H
    Rev Neurol (Paris); 1991; 147(5):399-403. PubMed ID: 1853038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postencephalitic stereotyped involuntary movements responsive to L-Dopa.
    Picard F; de Saint-Martin A; Salmon E; Hirsch E; Marescaux C
    Mov Disord; 1996 Sep; 11(5):567-70. PubMed ID: 8866499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Etiology of Parkinson's syndrome and disease].
    Honczarenko K; Kulcyzycki J
    Pol Tyg Lek; 1975 Jun; 30(25):1069-70. PubMed ID: 1135085
    [No Abstract]   [Full Text] [Related]  

  • 6. [Endocrine effects of bromocryptin in patients with Parkinsonism].
    Barreca T; Gianrossi R; Gallamini A; Nizzo MC; Queirolo A
    Boll Soc Ital Biol Sper; 1976 Oct; 52(19):1564-7. PubMed ID: 1037379
    [No Abstract]   [Full Text] [Related]  

  • 7. Parkinson's disease and related syndromes.
    Weiner WJ
    Med Sect Proc; 1993; ():195-203. PubMed ID: 8078870
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of biperiden in delayed-release form in the treatment of Parkinson's disease and parkinsonian syndromes of various etiologies. Clinical experiments].
    Puntoni U
    Clin Ter; 1983 Oct; 107(1):37-44. PubMed ID: 6653070
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term bromocriptine treatment of de novo patients with Parkinson's disease. A seven-year follow-up.
    Bergamasco B; Benna P; Scarzella L
    Acta Neurol Scand; 1990 May; 81(5):383-7. PubMed ID: 2375237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience with the use of parlodel in the treatment of Parkinson patients].
    Stoliarova LG; Kadykov AS; Shvedkov VV; Pivovarova VM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(2):219-22. PubMed ID: 3705825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bromocriptine in Parkinson's disease. Personal experience].
    Chacón JR; Piqueras L; Pery JM
    Arch Neurobiol (Madr); 1982; 45(5):371-80. PubMed ID: 7165448
    [No Abstract]   [Full Text] [Related]  

  • 12. [New possibilities in the therapy of Parkinson's syndrome using ParKS-Plus].
    Deze J
    Med Welt; 1974 Apr; 25(15):663-7. PubMed ID: 4825498
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of Parkinson's syndrome using a new preparation from the series of tricyclic psychotropic drugs].
    Deze J; Völler GW
    Med Welt; 1975 Aug; 26(33-34):1457-62. PubMed ID: 1100988
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hyperuricemia in Parkinson's syndrome--by chance or probable?].
    Babucke G; Sagebiel L; Mertz DP
    MMW Munch Med Wochenschr; 1976 Nov; 118(46):1489-90. PubMed ID: 825768
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of Parkinson's syndrome using L-dopa. 2].
    Glabb J; Hübner W; Glabb S
    Z Arztl Fortbild (Jena); 1973 Aug; 67(15):745-53. PubMed ID: 4594383
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bromocriptine and Parkinson's disease: initial results].
    Petit H; Destee A
    Lille Med; 1977; 22(6):362-5. PubMed ID: 578286
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study of bromocriptine and levodopa in Parkinson's disease.
    Duvoisin RC; Mendoza MM; Yahr MD
    Adv Biochem Psychopharmacol; 1980; 23():271-5. PubMed ID: 7395618
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination therapy of Parkinson's syndrome using L-dopa and a decarboxylase inhibitor].
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Med Welt; 1973 Nov; 24(45):1742-6. PubMed ID: 4768206
    [No Abstract]   [Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome. Efficacy of bromocriptine].
    Azorin JM; Bouchacourt M; Lavergne T; Giudicelli S
    Presse Med; 1984 Jun; 13(27):1702. PubMed ID: 6146134
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebral blood flow in Parkinson's syndrome.
    Granérus AK; Nilsson NJ; Suurküla M; Svanborg A
    Adv Neurol; 1984; 40():403-5. PubMed ID: 6695620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.